Very early researchUnknownNCT02707211
What this trial is testing
Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases
Who this might be right for
Lipid Metabolism, Inborn Errors
Universitaire Ziekenhuizen KU Leuven 20
Showing 12 of 0 results